LeadIQ logo
Learn more at LeadIQ.com
✕

Access Insights for Novome Biotechnologies and Millions of Other Companies

Sign up for full access to Novome Biotechnologies information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Insights

Growing Financial Backing Novome Biotechnologies secured $43.5 million in Series B financing, indicating strong investor confidence in the company's promising therapeutic approach. This substantial funding presents an opportunity for sales growth and expansion.

Established Industry Partnerships Partnerships with industry leaders like Genentech provide Novome Biotechnologies with access to advanced resources and expertise. Leveraging these collaborations can lead to enhanced market reach and potential sales opportunities through shared research efforts.

Strategic Leadership Additions The recent addition of Bill McLeod as Chief Financial Officer and Lachy McLean as Chief Medical Officer brings valuable experience to Novome Biotechnologies' leadership team. Their expertise can drive strategic decision-making and foster new avenues for sales growth.

Innovative Technology Stack Novome Biotechnologies utilizes a diverse tech stack including QuickBooks, Google Maps, and more. Leveraging innovative technologies can streamline operational processes, enhance product development, and create selling points for potential customers.

Market Penetration Potential With a focus on developing engineered microbial medicines for chronic diseases, Novome Biotechnologies has the potential to penetrate a growing market demand for innovative treatment solutions. This presents significant sales opportunities in a niche segment of the biotechnology industry.

Similar companies to Novome Biotechnologies

✕

Access Insights for Novome Biotechnologies and Millions of Other Companies

Sign up for full access to Novome Biotechnologies information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Novome Biotechnologies Tech Stack

Novome Biotechnologies uses 8 technology products and services including QuickBooks, Twitter Emoji (Twemoji), Slick, and more. Explore Novome Biotechnologies's tech stack below.

  • QuickBooks
    Accounting And Finance
  • Twitter Emoji (Twemoji)
    Font Scripts
  • Slick
    Javascript Libraries
  • Google Maps
    Maps
  • Google
    Miscellaneous
  • Popper
    Miscellaneous
  • Open Graph
    Miscellaneous
  • Intervals
    Time Tracking

Media & News

Novome Biotechnologies's Email Address Formats

Novome Biotechnologies uses at least 1 format(s):
Novome Biotechnologies Email FormatsExamplePercentage
FLast@novomebio.comJDoe@novomebio.com
49%
First@novomebio.comJohn@novomebio.com
1%
FL@novomebio.comJD@novomebio.com
1%
FLast@novomebio.comJDoe@novomebio.com
49%

Frequently Asked Questions

Where is Novome Biotechnologies's headquarters located?

Minus sign iconPlus sign iconNovome Biotechnologies's main headquarters is located at 279 E Grand Ave South San Francisco, CA 94080 US. The company has employees across 1 continents, including North America.

What is Novome Biotechnologies's official website and social media links?

Minus sign iconPlus sign iconNovome Biotechnologies's official website is novomebio.com and has social profiles on LinkedIn.

How much revenue does Novome Biotechnologies generate?

Minus sign iconPlus sign icon As of April 2024, Novome Biotechnologies's annual revenue reached $1.8M.

What is Novome Biotechnologies's SIC code NAICS code?

Minus sign iconPlus sign iconNovome Biotechnologies's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Novome Biotechnologies have currently?

Minus sign iconPlus sign iconAs of April 2024, Novome Biotechnologies has approximately 11 employees across 1 continents, including North America. Key team members include Ceo: B. W.Co-Founder: L. S.Co-Founder: P. B.. Explore Novome Biotechnologies's employee directory with LeadIQ.

What industry does Novome Biotechnologies belong to?

Minus sign iconPlus sign iconNovome Biotechnologies operates in the Biotechnology Research industry.

What technology does Novome Biotechnologies use?

Minus sign iconPlus sign iconNovome Biotechnologies's tech stack includes QuickBooksTwitter Emoji (Twemoji)SlickGoogle MapsGooglePopperOpen GraphIntervals.

What is Novome Biotechnologies's email format?

Minus sign iconPlus sign iconNovome Biotechnologies's email format typically follows the pattern of . Find more Novome Biotechnologies email formats with LeadIQ.

How much funding has Novome Biotechnologies raised to date?

Minus sign iconPlus sign icon As of April 2024, Novome Biotechnologies has raised $44M in funding. The last funding round occurred on Sep 13, 2022 for $44M.

When was Novome Biotechnologies founded?

Minus sign iconPlus sign iconNovome Biotechnologies was founded in 2016.
Novome Biotechnologies

Novome Biotechnologies

Biotechnology ResearchCalifornia, United States11-50 Employees

Novome is building genetically engineered microbial medicines (GEMMs) that perform defined activities in the human gut to treat chronic diseases. We have developed the first platform for controlled colonization of the gut with engineered therapeutic bacteria, and are applying this to multiple disease areas as well as expanding our platform capabilities. Our lead program in enteric hyperoxaluria is currently in Phase 2 clinical trials, and we are focusing current research efforts on making a microbial cell therapy to treat inflammatory bowel disease (IBD).

✕

Access Insights for Novome Biotechnologies and Millions of Other Companies

Sign up for full access to Novome Biotechnologies information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Section iconCompany Overview

Headquarters
279 E Grand Ave South San Francisco, CA 94080 US
Website
novomebio.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $44M

    Novome Biotechnologies has raised a total of $44M of funding over 6 rounds. Their latest funding round was raised on Sep 13, 2022 in the amount of $44M.

  • $10M

    Novome Biotechnologies's revenue is in the range of $10M

Section iconFunding & Financials

  • $44M

    Novome Biotechnologies has raised a total of $44M of funding over 6 rounds. Their latest funding round was raised on Sep 13, 2022 in the amount of $44M.

  • $10M

    Novome Biotechnologies's revenue is in the range of $10M

Company Leadership

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

✕

Access Insights for Novome Biotechnologies and Millions of Other Companies

Sign up for full access to Novome Biotechnologies information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.